Bioelectronics Corp (BIEL)

[DewmBoom]

$BIEL: Why Invest in BIEL ......Today before Tomorrow

This is not a company that is actively promoting the direct sale of its product as a priority right now. This is a value company with a portfolio of products that are patented and FDA approved with more approvals to come.

There are several reasons why you should invest in BIEL right now:

1. FDA full body approval of Actipatch for muscle and joint.....waiting for the approval as we speak

2. Bayer Dr Scholl’s licensing agreement......waiting for the deal as we speak

3. RecoveryRx approval and entry in the FDA innovation challenge.....We should hear something in November

4. Allay for menstrual pain. Clinical trial followed by 510 application is expected later this year. A new clinical trial for Allay is expected to be completed by October 1, by a prestigious institution in the UK with NHS foundation funding.

5. Actipatch for migraines.....currently under review after the completion of the clinical trial

6. Major US retailer.....Stay Tuned

7. More Licensing.....Stay Tuned

That is why Dewmboom has BIEL as his no. 1 STOCK PICK for 2018.


SLAP THE ASK and SLEEP LIKE A BABY $$$$$$$$